TCIM and hematologic disorder: Studies have shown that TC1 expression levels positively correlates with development of many malignancies including thyroid cancer [1, 17], gastric cancer [10], breast cancer [13], ovarian carcinomas [18], oral tongue squamous cell carcinomas [19], and hematological malignancies [20, 21].